Cargando…
Use of health care services and pharmaceutical agents in coeliac disease: a prospective nationwide study
BACKGROUND: Approximately 1% of the population suffer from coeliac disease. However, the disease is heavily underdiagnosed. Unexplained symptoms may lead to incremented medical consultations and productivity losses. The aim here was to estimate the possible concealed burden of untreated coeliac dise...
Autores principales: | Ukkola, Anniina, Kurppa, Kalle, Collin, Pekka, Huhtala, Heini, Forma, Leena, Kekkonen, Leila, Mäki, Markku, Kaukinen, Katri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503835/ https://www.ncbi.nlm.nih.gov/pubmed/23016889 http://dx.doi.org/10.1186/1471-230X-12-136 |
Ejemplares similares
-
Predictors of persistent symptoms and reduced quality of life in treated coeliac disease patients: a large cross-sectional study
por: Paarlahti, Pilvi, et al.
Publicado: (2013) -
Type 1 and type 2 diabetes in celiac disease: prevalence and effect on clinical and histological presentation
por: Kylökäs, Antti, et al.
Publicado: (2016) -
Gastrointestinal Symptoms in Celiac Disease Patients on a Long-Term Gluten-Free Diet
por: Laurikka, Pilvi, et al.
Publicado: (2016) -
Coeliac disease re‐screening among once seronegative at‐risk relatives: A long‐term follow‐up study
por: Paavola, Saana, et al.
Publicado: (2022) -
Significance of low ferritin without anaemia in screen‐detected, adult coeliac disease patients
por: Repo, Marleena, et al.
Publicado: (2022)